Related by context. Frequent words. (Click for all words.) 72 dose cohorts 69 mcg dose 69 mg kg dose 68 administered subcutaneously 68 phase IIa 67 Phase 2a trial 67 Phase 1b 66 nab paclitaxel 66 dose escalation 66 Pivotal Phase III 66 placebo controlled clinical 66 multiple ascending dose 65 Phase Ib 65 Phase 1a 65 Amrubicin 65 HER2 positive metastatic breast 65 Phase 2a 65 HGS ETR1 65 PROMACTA 65 mg QD 65 secondary efficacy endpoints 64 axitinib 64 Phase IIa trial 64 Phase 2b study 64 MIRCERA 64 dose limiting toxicities 64 Cloretazine R VNP#M 64 phase 2a 64 mg BID 64 mcg kg 64 blinded placebo controlled 64 dose regimens 64 tolerated dose MTD 64 KNS # 64 COPAXONE R 64 #mg dose [001] 64 decitabine 64 glufosfamide 64 elagolix 64 mg dose 64 Sym# 63 Pivotal Phase 63 azacitidine 63 relapsed refractory multiple myeloma 63 Phase Ia 63 placebo controlled studies 63 6R BH4 63 Diamyd ® 63 #mg dose [003] 63 virologic failure 63 abiraterone acetate 63 double blinded placebo 63 active comparator 63 alvimopan 63 pharmacokinetic studies 63 Phase 2b trial 63 subcutaneous injections 63 romiplostim 63 dose escalation trial 63 COPAXONE ® 63 LIALDA 63 phase IIb 63 serum uric acid 63 pharmacodynamic effects 63 Azedra 62 achieved statistical significance 62 teduglutide 62 CR# vcMMAE 62 plus methotrexate 62 FOLFIRI 62 Phenoptin 62 subgroup analyzes 62 registrational 62 adalimumab 62 dose escalation study 62 IMGN# 62 Phase III Clinical Trial 62 Phase IIa clinical trials 62 liver metastases 62 PRX # 62 tocilizumab 62 randomized #:# 62 serum concentrations 62 C1 INH 62 PRECiSE 62 nitazoxanide 62 placebo controlled trials 62 single ascending dose 61 Irinotecan 61 hemoglobin concentration 61 T2DM 61 Phase 2a clinical 61 eszopiclone 61 valopicitabine 61 sustained virologic response 61 cytogenetic response 61 CoFactor 61 aflibercept 61 placebo controlled randomized 61 thymalfasin 61 mg/m2